Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis

被引:38
作者
Wickham, S
Lu, B
Ash, J
Carr, DJJ
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA
[2] Childrens Hosp, Dept Med, Div Pulm, Boston, MA 02115 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA
关键词
chemokines; CXCL10; CXCR3; trigeminal ganglia; herpes simplex virus type 1;
D O I
10.1016/j.jneuroim.2005.01.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Herpes simplex virus type 1 (HSV-1) infection of the eye leads to the retrograde spread of the virus from the eye to the trigeminal ganglion resulting in the infiltration of leukocytes and production of inflammatory cytokines and chemokines including CXCL9 and CXCL10. The present study investigated the role of the receptor for CXCL9 and CXCL10 in the host response to HSV-1 infection using mice deficient in CXCR3 expression (CXCR3-/-). Although wild type C57BL/6 and CXCR3-/- mice cleared the virus, HSV-1 titers remained elevated in the ganglion and brain stem of CXCR3-/- mice day 7 post infection. Coinciding with the increase in virus titer, CCL5, CXCL9, CXCL10 and IFN-gamma protein levels were enhanced in the trigeminal ganglion and/or brain stem of the CXCR3-/- mice associated with a 2-fold increase in the percentage of CD3(+)CD8(+) T lymphocytes in the trigeminal ganglion. However, the survival rate of CXCR3-/- mice was significantly enhanced above the wild type controls associated with an increase in brain IL-6 content. Collectively, the results indicate the absence of CXCR3 is associated with a transient increase in virus burden in the nervous system and an elevated protective immune response. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 42 条
[1]   Interleukin 1α and interleukin 6 protect human neuronal SH-SY5Y cells from oxidative damage [J].
Bissonnette, CJ ;
Klegeris, A ;
McGeer, PL ;
McGeer, EG .
NEUROSCIENCE LETTERS, 2004, 361 (1-3) :40-43
[2]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[3]   Investigations on four host response factors whose expression is enhanced in X4 SHIV encephalitis [J].
Buch, S ;
Sui, YJ ;
Dhillon, N ;
Potula, R ;
Zien, C ;
Pinson, D ;
Li, SP ;
Dhillon, S ;
Nicolay, B ;
Sidelnik, A ;
Li, CC ;
Villinger, T ;
Bisarriya, K ;
Narayan, O .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 157 (1-2) :71-80
[4]   GAMMA-INTERFERON EXPRESSION DURING ACUTE AND LATENT NERVOUS-SYSTEM INFECTION BY HERPES-SIMPLEX VIRUS TYPE-1 [J].
CANTIN, EM ;
HINTON, DR ;
CHEN, J ;
OPENSHAW, H .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4898-4905
[5]   The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4+, α/β T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon [J].
Carr, DJJ ;
Noisakran, S .
JOURNAL OF VIROLOGY, 2002, 76 (18) :9398-9406
[6]   Failure to maintain adherence to HAART in a cohort of french HIV-positive injecting drug users [J].
Carrieri, MP ;
Chesney, MA ;
Spire, B ;
Loundou, A ;
Sobel, A ;
Lepeu, G ;
Moatti, JP .
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2003, 10 (01) :1-14
[7]   Cutting edge:: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity [J].
Cole, AM ;
Ganz, T ;
Liese, AM ;
Burdick, MD ;
Liu, L ;
Strieter, RM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :623-627
[8]  
Coles JM, 1998, PACIF RIM ARCHAEOL, V1, P3
[9]  
Daigle J, 1998, J IMMUNOL, V160, P3060
[10]   IFN-γ-Inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking [J].
Dufour, JH ;
Dziejman, M ;
Liu, MT ;
Leung, JH ;
Lane, TE ;
Luster, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3195-3204